Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry.
about
The genetic epidemiology of neurodegenerative disease.Validation of the neuropathologic criteria of the third consortium for dementia with Lewy bodies for prospectively diagnosed casesNeuropathology of non-Alzheimer degenerative disordersTau Oligomers: The Toxic Player at Synapses in Alzheimer's DiseasePsychosis in Alzheimer's diseasePathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body diseaseNeuropathological alterations in Alzheimer diseaseAlpha-synuclein biology in Lewy body diseasesCross-seeding of misfolded proteins: implications for etiology and pathogenesis of protein misfolding diseasesPlasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease.Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies.The Synaptic Function of α-SynucleinNeuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies?Seeking a mechanism for the toxicity of oligomeric α-synucleinAlpha-synuclein and tau: teammates in neurodegeneration?Gray matter atrophy associated with extrapyramidal signs in the Lewy body variant of Alzheimer's disease.Evaluation of alpha-synuclein immunohistochemical methods used by invited expertsInteractions between Tau and α-synuclein augment neurotoxicity in a Drosophila model of Parkinson's disease.Diagnostic Values of Cerebrospinal Fluid T-Tau and Aβ₄₂ using Meso Scale Discovery Assays for Alzheimer's DiseaseMagnetic resonance spectroscopy in common dementiasA scFv antibody targeting common oligomeric epitope has potential for treating several amyloidoses.Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements.Alpha-Synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson's disease models.Dissecting the Molecular Mechanisms of Neurodegenerative Diseases through Network BiologyMice expressing the A53T mutant form of human alpha-synuclein exhibit hyperactivity and reduced anxiety-like behaviorPrevalence of Submandibular Gland Synucleinopathy in Parkinson's Disease, Dementia with Lewy Bodies and other Lewy Body Disordersbeta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease.Region-specific tauopathy and synucleinopathy in brain of the alpha-synuclein overexpressing mouse model of Parkinson's diseaseAlzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy.Tau enhances α-synuclein aggregation and toxicity in cellular models of synucleinopathy.Tau reduction does not prevent motor deficits in two mouse models of Parkinson's diseaseIron, zinc and copper in the Alzheimer's disease brain: a quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinionCerebrospinal fluid biomarkers for dementia with lewy bodies.MicroRNA-153 physiologically inhibits expression of amyloid-β precursor protein in cultured human fetal brain cells and is dysregulated in a subset of Alzheimer disease patients.From model system to clinical medicine: pathophysiologic links of common proteinopathies.Evaluating the relationship between amyloid-β and α-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson's disease.National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's diseaseLocal amygdala structural differences with 3T MRI in patients with Alzheimer disease.Tauopathic changes in the striatum of A53T α-synuclein mutant mouse model of Parkinson's disease.Genetic association between the APOE*4 allele and Lewy bodies in Alzheimer disease.
P2860
Q22306301-A17DEFC6-1092-4C5E-8F2A-24A287D6DD54Q24653609-B7FAC72E-58AF-4102-9E46-A643C60CF8D6Q24657571-925CB64D-E0A6-4F8B-9016-13AB4AC25522Q26773154-804D6E7B-72E6-40B9-9630-6328774BE081Q26824635-3F3CDB51-14F6-42F2-B264-02E2B56A546FQ26853610-41F2C317-C3F3-493E-BEB4-B1FC154ABB50Q27003314-A73C51D9-7EFF-4E5A-9774-E8FA16732FEBQ27003541-225E8CB0-FEAA-4793-9300-56431B16030EQ27021846-52A7F038-6F8E-404F-AC6A-3DE90CB3F5C1Q27322563-0496699A-AA82-43B4-A678-22B70F58FC48Q27686837-750D0C44-0821-4ED7-88BA-D2F69036CE42Q27694711-04340B56-AC90-4944-AE17-DD99FCCD13BDQ28070156-3D3AB15B-D583-4CBA-8373-71AA8AD787C9Q28080551-85CDA078-3860-4F41-B1A5-BF0D3E8426D3Q28250508-A3664737-AAFE-4F05-919B-C11AA8FF92CCQ30421996-4F8BDC16-13D7-45DE-8D7B-AED1C0431486Q30488694-A822F2DF-A90F-4C87-8BF0-1BAF3F7941B5Q30577687-DACC664F-FB5F-4D77-91FA-0C7F35C7F97FQ30659251-5E0BBF2A-312D-4F6D-A3D8-40A0DBFFDDD9Q30660402-B97E3E3F-A263-4036-B993-321E79261434Q30827953-C160F3BF-C9F9-426D-896F-6F7EE35A15C8Q31159878-6F7B9192-07AD-4D84-9D86-02AD88B78801Q33552220-DFDB9EEA-32BA-472E-85B2-9CB63AFCDA93Q33734563-055F4125-AA70-46D2-9701-E4272341125EQ33817178-0945796E-0BA4-4EF9-B42E-CBDF18035A0FQ33874572-DC5F15E1-CCA6-45F7-8089-5A745D37FB9DQ33947152-0C989B34-FB77-4275-A45D-F307F716FDAFQ33980640-B681702C-D7CD-4B7D-9BED-DBCB632A79B6Q33997481-8AC1D9A0-1F26-4A34-A0DD-CD659291BE0CQ34062509-82197EEC-1DEF-40FC-888E-609BE76849B6Q34113712-8BA2AF99-716E-43BC-B31B-F62B09563A50Q34186434-7AE27BA2-49A5-4CEB-9FAF-5CC0B216E708Q34248241-3CBB734D-AC55-4116-BB3D-6F45571DA17CQ34284143-CDC30A06-576F-4B91-915F-7F22F0B75636Q34318017-47623A3D-D67F-477E-8D11-E9A7E2B130ECQ34591096-688788A1-D302-4CBD-9D60-9EF7954AB066Q34635272-EC82B4E7-58CE-4E9B-AEE1-5D271C613A7EQ34647031-8CB72D66-D3A3-4707-8D01-96C856ABB037Q34704153-C1D6CFBD-D9A7-4103-BFCC-54E59BA1025BQ34709035-61B63AA5-A0D8-4C98-847B-AA59D5926FCF
P2860
Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Lewy bodies in Alzheimer's dis ...... ynuclein immunohistochemistry.
@ast
Lewy bodies in Alzheimer's dis ...... ynuclein immunohistochemistry.
@en
type
label
Lewy bodies in Alzheimer's dis ...... ynuclein immunohistochemistry.
@ast
Lewy bodies in Alzheimer's dis ...... ynuclein immunohistochemistry.
@en
prefLabel
Lewy bodies in Alzheimer's dis ...... ynuclein immunohistochemistry.
@ast
Lewy bodies in Alzheimer's dis ...... ynuclein immunohistochemistry.
@en
P921
P1433
P1476
Lewy bodies in Alzheimer's dis ...... synuclein immunohistochemistry
@en
P2093
R L Hamilton
P304
P356
10.1111/J.1750-3639.2000.TB00269.X
P577
2000-07-01T00:00:00Z